ASX Share rice
Sat 08 Aug 2020 - 06:24:pm (Sydney)

GMV Share Price

G MEDICAL INNOVATIONS HOLDINGS LIMITEDGMVHealth Care Equipment & Services

GMV Company Information

Name:

G Medical Innovations Holdings Ltd

Sector:

Healthcare

Industry:

Medical Instruments & Supplies

GIC Industry:

Health Care Technology

GIC Sub Industry:

Health Care Technology

Address:

1500 Lakeside Dr. Bannockburn IL United States 60015

Phone:

345 749 2000

Pres, CEO, MD & Exec. Director:

Dr. Yacov Geva

Chief Financial Officer:

Mr. Kobi Ben-Efraim

Chief Operating Officer:

Mr. Rafi Heumann

Chief Technology Officer:

Mr. Nir Geva

Sr. VP of Mergers & Acquisitions:

Mr. Oded Shahar

Company Overview:

G Medical Innovations Holdings Ltd, together with its subsidiaries, operates as a mobile health and e-health company. It develops and markets clinical and consumer medical-grade health monitoring solutions; and offers support for e-health projects. The company develops Medical Smartphone Case, a solution that turns a phone into a mobile medical monitor; and G Medical Patch, a solution that provides continuous and real-time monitoring of a range of patient vital signs and biometrics. G Medical Innovations Holdings Ltd was founded in 2014 and is based in Bannockburn, Illinois.

GMV Share Price Information

Shares Issued:

714.72M

Market Capitalisation:

$40.02M

Revenue (TTM):

$5.53M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.041

Profit Margin:

-2.7168

Operating Margin (TTM):

$-2.31

Return On Assets (TTM):

$-0.70

Return On Equity (TTM):

$-20.77

Quarterly Revenue Growth (YOY):

0.27

Gross Profit(TTM):

$-223,000

Diluted Earnings Per Share (TTM):

$-0.039

GMV CashFlow Statement

CashFlow Date:

2019-12-31

Investments:

$-612,332.29

Change To Liabilities:

$0.94M

Total Cashflow From Investing Activities:

$-429,000

Net Borrowings:

$4.10M

Net Income:

$-21,428,775.34

Total Cash From Operating Activities:

$-6,297,000

Depreciation:

$2.95M

Change To Inventory:

$0.98M

Change To Account Receivables:

$149K

Capital Expenditures:

$612.33K

GMV Income Statement

Income Date:

2019-12-31

Income Before Tax:

$-23,359,977.16

Net Income:

$-21,428,775.34

Gross Profit:

$-318,298.60

Operating Income:

$-18,244,361.98

Interest Expense:

$5.49M

Income Tax Expense:

$-857,000

Total Revenue:

$7.89M

Total Operating Expenses:

$17.93M

Cost Of Revenue:

$8.21M

GMV Balance Sheet

Balance Sheet Date:

2019-12-31

Total Liabilities:

$26.61M

Total Stockholder Equity:

$-19,093,634.03

Other Current Liabilities:

$4.71M

Total Assets:

$12.52M

Common Stock:

$410K

Other Current Assets:

$717K

Retained Earnings:

$-90,408,221.52

Other Liabilities:

$5K

Good Will:

$4.06M

Other Assets:

$71K

Cash:

$1.02M

Total Current Liabilities:

$24.41M

Short-Term Debt:

$12.42M

Property - Plant & Equipment:

$3.48M

Net Tangible Assets:

$-16,221,000

Total Current Assets:

$3.39M

Long-Term Debt:

$1.84M

Net Receivables:

$793.61K

Short-Term Investments:

$9.13M

Inventory:

$539.54K

Accounts Payable:

$4.75M

Non Currrent Assets (Other):

$101.34K

Short-Term Investments:

$9.13

Non Current Liabilities Total:

$2.21M

GMV Share Price History

GMV News

20 May, 2020
Medical device and telehealth company G Medical Innovations Holdings Ltd (ASX: GMV) ("G Medical" or "Company") is pleased to report a significant development for the Company with receipt of Emergency Use Authorisation ("EUA") status from the US Food and Drug Administration ("FDA") for the Company's Vital Signs Monitoring System ("VSMS") ECG Patch ("Patch") for the remote monitoring of the QT interval of an ECG in patients who are undergoing treatment in a hospital setting for COVID-19 with drugs that can prolong QT intervals and may cause fatal arrhythmias.
22 Oct, 2019
If you want to know who really controls G Medical Innovations Holdings Ltd (ASX:GMV), then you'll have to look at the...